Struggling with Clinical Trial Costs and Talent Shortages?

The Functional Service Provider (FSP) model offers a flexible and cost-effective alternative. Get the insights you need to make a successful transition by downloading our new whitepaper.

Get Your Free Whitepaper

Modernizing Clinical Trials - Simple Design Cover

What's Inside?

A Detailed Comparison

A deep dive into how the FSP model outperforms FSO and traditional staffing models across key metrics like cost, control, and talent retention.

Industry Trends

A look at why a growing number of pharmaceutical and biotech companies are shifting to FSP models, validating it as a trusted approach to modernizing trials.

Strategic Benefits

Comprehensive coverage of FSP's impact on talent acquisition, operational efficiency, regulatory compliance, and global expansion.

Real-World Case Studies

Learn how FSP models are being used by both large pharmaceutical companies and small-to-mid-sized biotech firms to accelerate growth and optimize operations.

About The Authors

Benjamin P. Stephenson, MBA

Benjamin P. Stephenson is a senior executive with nearly two decades of experience leading global clinical operations and workforce strategy in the pharmaceutical, biotech, and medical device industries. As Senior Vice President of Global FSP Operations and Strategy at Vita Global Sciences, he partners with top-tier life sciences organizations to design and implement scalable, compliant FSP models that support clinical, regulatory, and medical functions across 35+ countries.

With deep expertise in aligning operational delivery to R&D objectives, Benjamin enables sponsors to optimize resource deployment, accelerate study timelines, and enhance continuity through tailored functional resourcing strategies. He leads diverse teams of program managers, talent acquisition experts, and engagement specialists who deliver consistent execution, measurable results, and exceptional client service.

Previously, Benjamin held senior leadership roles at Kelly Services, where he helped shape and expand global FSP capabilities supporting leading pharma and device clients. He is also a former Executive Steering Council member of the Association of Clinical Research Professionals (ACRP), where he advanced initiatives focused on increasing diversity and inclusion in clinical trials and the research workforce.

Benjamin holds a bachelor’s degree in Human Biology and Health Care Administration from the University of Michigan and an MBA in Strategic Leadership. He is certified in cGMPs, LEAP (Lead, Engage, Advance, Perform), and InsideOut Coaching. His leadership has earned industry honors including the SET Legends Circle Award and Kelly Honors Finalist for “Winning Through Our People.”

Emmanuelle Hoarau, PhD

With a PhD and deep domain expertise, Emmanuelle Hoarau serves as Domain Intelligence Director at Kelly Science & Clinical, based in the Paris region. In this leadership role, she oversees market insights and strategic talent intelligence across life sciences, bridging science, engineering, and medical device sectors to deliver impactful hiring and workforce solutions.

She leads a team focused on identifying industry trends and connecting top scientific talent with organizations at the forefront of biotech, pharmaceuticals, and biomanufacturing. Her data-driven approach helps clients build teams aligned with current and emerging needs in research and operations.

A recognized thought leader, Emmanuelle frequently shares insights on drug discovery, biomanufacturing, and medical devices through LinkedIn and webinars, with a focus on topics like AI in drug development and life sciences talent trends. She has built a strong professional following, known for her expertise and engagement in domain intelligence.

Emmanuelle’s leadership combines analytical rigor, industry insight, and a passion for advancing scientific excellence within her clients’ organizations.

Transform Your Clinical Trials with the FSP Strategic Framework

Discover how the Functional Service Provider (FSP) model is helping biopharma companies overcome rising costs and talent shortages to accelerate drug development.

Download the Strategic Guide